Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX)

CUSIP: 14161W105

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock, par value $0.0001
Shares outstanding
53,041,500
Total 13F shares
25,018,920
Share change
+2,583,446
Total reported value
$1,750,601,005
Put/Call ratio
46%
Price per share
$69.98
Number of holders
164
Value change
+$226,035,991
Number of buys
113
Number of sells
65

Quarterly Holders Quick Answers

What is CUSIP 14161W105?
CUSIP 14161W105 identifies CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q2 2020

As of 30 Jun 2020, Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) was held by 164 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,018,920 shares. The largest 10 holders included CAS Investment Partners, LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, KPS Global Asset Management UK Ltd, 683 Capital Management, LLC, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, and Antipodean Advisors LLC. This page lists 164 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.